Abstract

The present invention relates to a novel process for the preparation of 4- [(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane- 2-amido]pyridine -2-carboxamide represented by the following structural Formula-1, which is referred to as Suzetrigine.

Formula-1

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS